Atavistik Bio

US pharmaceutical giant Pfizer (NYSE: PFE) has entered into a research collaboration with compatriot firm Atavistik Bio, with the aim of bolstering the discovery of novel precision allosteric therapeutics to address significant unmet medical needs. Leverage of Atavistik Bio’s AMPS PlatformUnder the agreement, Atavistik Bio will utilize its proprietary AMPS…